Tuesday, December 20, 2016

TSX Mining News: Silver Spruce (TSXV: $SSE.V) Reports 8 g/t Gold and 77 g/t Silver at Encino De Oro

TSX Mining News: Silver Spruce (TSXV: $SSE.V) Reports 8 g/t Gold and 77 g/t Silver at Encino De Oro

Receives Significant Geochemical Results from Encino De Oro Gold & Silver Project

December 20, 2016 (Investorideas.com Newswire) Silver Spruce Resources Inc. (TSXV: SSE.V) announced the latest sampling results from its recently acquired Encino De Oro project near Chinipas, Chihuahua, Mexico. The field crew was led by Leonard J. Karr, P.Geo, and a third party qualified person for Silver Spruce.

To date, a total of 42 chip channel and grab samples have been taken from outcrop, sub crop and float over an area of three square kilometres at the Encino De Oro project.
Assays of these samples range as high as 8 grams per tonne gold (Au) and 77 g/t silver (Ag), with anomalous values of copper (Cu), lead (Pb), zinc (Zn), arsenic (As) and antimony (Sb).


Encino De Oro Property
The Encino De Oro project contains vein, stock work and disseminated hosted epithermal gold-silver targets within the upper and lower volcanic sequences. An initial property examination in October, 2016, confirmed that an outcrop of strongly silicified rhyolite tuff contains gold grades of eight g/t and greater than five g/t in two samples covering over three metres in width. The company's field reconnaissance team, led by Mr. Karr, examined this outcrop in November, 2016.

This reconnaissance showed mineralization and argillic alteration to be widespread, covering about three square kilometres and being open on all sides. About 90 per cent of the exposed section consists of rhyolitic tuffs that are weakly to moderately argillized and locally contain quartz stockwork. Rarely weakly to moderately silicified zones were encountered.
Additionally, local anomalies in Ag, As, Cu, Pb, Zn and Sb together are suggestive of a large system that warrants additional work.

Qualified person
Mr. Karr, professional geologist and a qualified person, under Toronto Stock Exchange guidelines, is the author of the company's NI 43-101 report on the Pino de Plata project, dated July 7, 2015, and is responsible for the technical content of this press release.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

David Joseph
604-569-1801
davidjosephmarketing@telus.net











Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. The following is a paid for news release on Investorideas.com

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Friday, December 16, 2016

#InvestorIdeas Adds #Marijuana/ #Hemp, #Technology, #Mining, #Energy & #Biotech #Stocks to Directories

#Marijuana/ #Hemp #Stocks $ACOL, $ACAN, $CANL, $CRTL, $ETST, $EMC.V, $CHV.CA, $CRZ.CA Just added

Investorideas Also Adds #Technology, #Mining, #Energy & #Biotech Stocks



Point Roberts, WA, Delta BC – December 16, 2016 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its membership global stock directories in marijuana/hemp, technology, mining, energy and biotech.

Marijuana/hemp additions include Canadian and US listed companies involved in Cannabidiol Oil, hemp-based clothing, medical and recreational marijuana, medical storage containers (for medical marijuana) and a business services company that is cannabis industry specific.

The latest tech company to be added is Ericsson (Nasdaq:ERIC) a company that enjoys relationships with every major telecom operator in the world.  Look for our exciting new sector “Artificial Intelligence (AI) & Robotics” in next week’s update.

Canadian oil and natural gas company Petrolympic (TSX: PCQ.V; OTCQB: PCQRF), based out of Quebec has been added to both the natural gas stock directory and the oil and gas stock list.

In the mining sector, three new Canadian companies have been added – two involved in exploration and one in the acquisition and management of royalties.

The latest biotech additions focus on women’s health, cardiovascular disease, Wilson Disease, (a genetic disorder that causes copper to build up in the body), respiratory disease and a company dedicated to therapeutic antibody discovery and commercialization.


New Marijuana Companies Added:
Acology Inc (OTC:ACOL), Americann Inc (OTC:ACAN), Canada House Wellness Group Inc.(CSE:CHV), CannaRoyalty Corp. (CSE:CRZ), CannLabs Inc (OTC:CANL), Cartel Blue (OTC:CRTL), Earth Science Tech Inc (OTC:ETST) and Emblem Corp. (TSX:EMC.V)
  
New Technology Companies Added:
Ericsson (Nasdaq:ERIC) is the driving force behind the Networked Society - a world leader in communications technology and services. Our long-term relationships with every major telecom operator in the world allow people, business and society to fulfill their potential and create a more sustainable future. Our services, software and infrastructure - especially in mobility, broadband and the cloud - are enabling the telecom industry and other sectors to do better business, increase efficiency, improve the user experience and capture new opportunities. With approximately 115,000 professionals and customers in 180 countries, we combine global scale with technology and services leadership. We support networks that connect more than 2.5 billion subscribers. Forty percent of the world's mobile traffic is carried over Ericsson networks. And our investments in research and development ensure that our solutions - and our customers - stay in front. Founded in 1876, Ericsson has its headquarters in Stockholm, Sweden.
New Mining Companies Added:
Goldbelt Empires Limited (TSX: GBE.V) is a gold explorer focused on the West African Goldbelt, and listed its shares on the TSX Venture Exchange in October 2015. Its flagship property is the South Morila gold concession in the Republic of Mali. The South Morila concession covers an area approximately 150 km2 in size, and is located in the southern part of Mali approximately 250 km southeast of the capital of Bamako

Jaxon Minerals (TSX:JAX.V)  is a base and precious metals exploration company with a regional focus on Western Canada. The company is currently advancing its optioned Price Creek property in north-central British Columbia. The property has seen considerable historic exploration work and presents a volcanogenic massive sulphide-style target with reported potential Eskay Creek/Equity silver- style mineralization.

Metalla Royalty and Streaming Ltd. (formerly Excaliber Resources) (CSE:MTA) is a precious metals royalty and streaming company engaged in the acquisition and management of precious metal royalties, streams and similar production based interests. 

New Energy Companies Added:
Petrolympic Ltd. (TSX: PCQ.V; OTCQB: PCQRF) is a Canadian junior oil and gas company actively exploring for premium light crude oil and natural gas in North America. The Company is presently focused on its near-term conventional oil and natural gas production assets in the Gaspe Peninsula, Province of Quebec, Canada. The Company also holds natural gas assets in the Utica Fairway of Quebec and an 8,000+ acre asset in the oil-prolific Maverick Basin of Texas, USA. The land position in Quebec consists of 100% interest in 5 exploration permits over 239,296 acres (96,840 hectares), 30% interest in 36 exploration permits totaling 1,601,466 acres (648,093 hectares) and 12% interest in 19,768 acres (8,000 hectares). Petrolympic is targeting hydrothermal dolomite and naturally fractured hosted conventional light oil and natural gas in areas where hydrocarbon shows have been previously documented in geological outcrop sampling and coring programs together with its private joint venture partner Ressources et Energie Squatex Inc. The partnership has recently discovered a conventional gas reservoir, heavy oil and condensates in the Masse structure located in the Gaspe Peninsula.

New Biotech Companies Added:
Juniper Pharmaceuticals, Inc. (NasdaqGS:JNPis focused on developing therapeutics that address unmet medical needs in women's health. The Company is advancing a pipeline of proprietary product candidates that leverage its differentiated intravaginal ring technology and the 505(b)(2) regulatory pathway. Juniper's core operating business includes the Crinone® (progesterone gel) franchise and Juniper Pharma Services, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing to clients.

Quantum Genomics (Paris:ALQGC.PA) is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure. Quantum Genomics is developing a new therapeutic approach based on BAPAI (Brain Aminopeptidase A Inhibition). This is the result of more than 20 years of academic research in the laboratories of the Collège de France, INSERM, CNRS and the University of Paris Descartes. The Company has offices in Paris, France and New York, NY, USA.

uniQure N.V. (NasdaqGS:QUREis delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with liver/metabolic, central nervous system and cardiovascular diseases.

Wilson Therapeutics AB (Stockholm: WTX.STis a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases. Wilson Therapeutics’ lead product, WTX101, is initially being developed as a novel treatment for Wilson Disease and has been evaluated in a Phase 2 clinical study. Wilson Therapeutics is listed in the Mid Cap segment on Nasdaq Stockholm with the stock ticker WTX.

Windtree Therapeutics, Inc. (NasdaqCM:WINTis a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree's proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies.

XBiotech USA, Inc. (NasdaqGS:XBITis a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human(TM) proprietary technology. XBiotech currently is advancing a robust pipeline of antibody therapies to redefine the standards of care in oncology, inflammatory conditions and infectious diseases. Headquartered in Austin, Texas, XBiotech also is leading the development of innovative biotech manufacturing technologies designed to more rapidly, cost-effectively and flexibly produce new therapies urgently needed by patients worldwide.

Investorideas.com global stock directories are part of its membership program, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  
Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411


Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory











#Cannabis Stock News: Alliance Growers (CSE: $ACG) Announces Extension with BRIM For MJ Botany Centres

#Cannabis Stock News: Alliance Growers (CSE: $ACG) Announces Extension with BRIM For MJ Botany Centres

December 16, 2016 (Investorideas.com Newswire) Alliance Growers (CSE: ACG)and Botanical Research In Motion International Inc. (BRIM) have agreed to extend the period of time required to finalize the definitive licence agreement.

Alliance is finalizing a Definitive License Agreement with B.R.I.M. for a Canada Exclusive License to jointly develop and operate cannabis Botany Centres. The initial project is planned as a staged development of a 40,000 square foot facility being located near Vancouver, B.C., to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the cannabis market and agriculture market in general. The planned facility will grow cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity.

The development of the cannabis botany centre, together with partnerships and investments, is designed to provide Alliance Growers with the following:

·        Produce revenue from the sale of cannabis and other plantlets under contract;
·        Generate revenue from the processing and resale of cannabidiol (CBD) oil in Canada, the United States and offshore;
·        Providing cold-storage facilities utilizing the one-of-a-kind cryo-tissue cold-storage technology for tissue culture preservation and regeneration as needed on a long-term basis;
·        Provide extraction services as retail services for cultivators and create custom profiles for extraction for botanicals oils for retail market.

First strategic investment in a private medical cannabis company
Through a serious of strategic partnerships and investments under negotiation with licensed producers at various stages in the licence process, Alliance Growers is focused on securing long-term plantlet sale contracts for the cannabis botany centre and off-take agreements at wholesale costs for flowers to be acquired by Alliance Growers for CBD oil extraction.
Alliance Growers has negotiated terms on a 10-per-cent non-dilutive interest in a private company in Ontario that has assembled a top-tier growing team with management that has the expertise to expedite the licensed producer application process.

Joint venture with Israeli medical cannabis company
Further to the company's commitment to become a leading supplier of pharmaceutical-grade CBD oil on a global basis, Alliance Growers continues discussions setting out terms with an Israeli medical cannabis company.

Included in the discussions is the joint development of 50 hectares of land for the growth of high-quality cannabis plants, as legally permitted in an offshore, low-operating-cost jurisdiction. This would facilitate the importation of the CBD oil into various states in the United States, into Canada when legalized and into other countries as permitted.

This joint venture and other similar partnerships are what will make Alliance Growers stand out from other Canadian cannabis companies that are directly affected by Health Canada rules and regulations. Alliance Growers plans to produce and sell more CBD oil from outside Canada.

The Hemp Business Journal reports that the CBD market in the United States is growing at a rate of 30 per cent per year and forecasts that sales of CBD oils from marijuana-based sources are expected to reach $1.65-billion, or 79 per cent of the total CBD market of $2.1-billion, by 2020.

As previously announced, Alliance Growers is undertaking a private placement of up to 10 million units at a price of 20 cents per unit, for gross proceeds of up to $2-million. Each unit comprises one common share and one share purchase warrant. Each share purchase warrant will entitle the holder to acquire one additional common share in the capital of the company at a price of 30 cents per share, for a period of two years from the date the units are issued. A portion of the proceeds may be used for finalization of the company's current projected arrangements.

About Alliance Growers
Alliance Growers is a diversified cannabis company driven by the company's four-pillar organization plan: MMPR (marihuana for medical purposes regulations) cannabis production facilities, distribution network, consumer products, and research and development.

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.



Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. The following is a paid for news release on Investorideas.com
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Wednesday, December 14, 2016

NEXUS GOLD (TSX.V: NXS) Starts Drilling Gold Project Niangouela

NEXUS GOLD (TSX.V: NXS) Starts Drilling Gold Project Niangouela

NEXUS GOLD (TSX.V: NXS) RAB DRILLING UNDERWAY AT NIANGOUELA GOLD CONCESSION, BURKINA FASO, WEST AFRICA

December 14, 2016 (Investorideas.com Newswire) Nexus Gold Corp.'s (TSX.V: NXS.V) RAB (rotary air blast) drilling at its Niangouela gold concession in Burkina Faso, West Africa, is now under way.

Drilling began on Monday, December 12, with 294m (eleven holes) of the proposed 800m program so far completed. The current RAB program is designed to investigate the potential of parallel or offset shears and recently observed quartz veins. Historic results showed areas of geochemical anomalies occurring proximal to the quartz veining. The program will consist of grid drilling on lines spaced at 200 meters with drill sites every 50 meters along the lines.

The 178 square kilometre concession is located on the Boromo Greenstone Belt, same as the Company's Bouboulou Gold Concession and is proximal to the Kalsaka deposit and the Sabce shear. It is road accessible and has one major orpaillage (artisanal workings).

To date 556 pits and eleven trenches have been excavated, and rock and soil samples have been taken. A total of 1,137 samples have been collected. Previous programs have identified a zone which runs ENE and WSW occurring in the south central part of the concession. This zone has returned gold in soil samples up to 34 g/t Au, rock samples have returned values up to 18 g/t Au, and trenching has returned values of 4.85 g/t Au over 10 meters.


About Burkina Faso
Burkina Faso is a landlocked nation, located in West Africa. It covers an area of roughly 274,000 square kilometres and has an estimated population of more than 16 million people. The country has a stable political setting with a pro-mining and foreign investment stance. Burkina Faso is the fastest growing gold producer in Africa, and was the 4th largest gold producer in Africa in 2012. Eight new mines have been commissioned there over the past six years. The country has excellent geological potential. The Greenstone Belts that host all of the major deposits in Ghana and Cote d'Ivoire continue northward into Burkina Faso. Burkina Faso has undergone less than 15 years of modern mineral exploration, remaining under explored in comparison to neighbouring Ghana and Mali; both of which host world class gold mines in the same belts of Birimian rocks.

About the Company
Nexus Gold Corp. is a Vancouver-based gold exploration and development company operating in some of the world's premier mining districts. The Company is currently concentrating its efforts on two gold projects located in Burkina Faso, West Africa. The Bouboulou gold concession is a 38-sq km advanced exploration target where previous drilling has confirmed multiple zones of gold mineralization, and the Niangouela gold concession, a 178-sq km project featuring numerous historical gold occurrences. For more information on these projects, please visit the company website at www.nexusgoldcorp.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

David Joseph
604-569-1801
davidjosephmarketing@telus.net












Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. The following is a paid for news release on Investorideas.com
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Tuesday, December 13, 2016

Medical Marijuana Company Interview: CEO of Profile Solutions, Inc. (OTC: $PSIQ) Talks about How Biometrics Can Play a Role in Securing and Storing Medical Marijuana

Point Roberts, WA, – December 13, 2016 – Investorideas.com, a global news source and investor resource covering actively traded sectors including marijuana and hemp stocks issues an exclusive interview with the CEO of Profile Solutions, Inc. (OTC: PSIQ), a company creating products for the Medical and Recreational Cannabis-related industry. http://www.profilesolutionsinc.com/


Q: Investorideas
Dore, your company and personal background is in security and biometrics. Can you give us a brief history of your expertise and experience in that space?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
Being involved in the security industry for over 20 years, I have witnessed great improvement in various technologies regarding access and identification of people and property. Some of these technologies have become almost foolproof and have become part of our everyday lives, from banking to getting through the door at your job. From 1997 to 2008 I was the CEO of Sense Holdings and later China America Holdings. Sense was involved in the development, design, sales and support of a proprietary access control and time and attendance solution that was sold to law enforcement including the Department of Corrections, Fortune 100 Corporate customers and privately owned businesses. The technology was based on biometrics which is identifying the user by a physical characteristic, fingerprint, vein, voice, face, etc.  Our technology was primarily fingerprint, so the employee or user was granted access by placing their finger on our scanner.  We sold and installed our solutions to major airlines, prisons and the transportation industry. This technology allowed us to monitor fraud and better control access to unsupervised locations.


Q: Investorideas
You are now taking that technology background and creating products for the medical marijuana industry with access control solutions and a new MedSafe - Secure Pharmaceutical Depository. Are there other applications for it as well?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
Our main focus is to make sure children or any unauthorized person doesn’t get into something they shouldn’t be allowed to. With the expansion of the cannabis industry for both medical and recreational in multiple states, the increased popularity of edibles which are cannabis-infused candies, baked goods, and drinks, have become a big problem (a child going into the fridge and eating a chocolate bar that looks harmless). Our PSI Medsafe is based on positive identification so no one is granted access that is not allowed to. Our unit is climate controlled to keep all medications at perfect temperature, and has the ability to communicate wirelessly to the authorized user.

Our technology can also be used for various medical applications, doctor’s offices and hospitals and can also be used as a personal storage device for jewelry or valuables.


Q: Investorideas
Can you talk about the primary technology and then more specifically about MedSafe?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
Our technology is proprietary with some standard off the shelf components. We currently have a patent in process. Our custom communication controller will talk from the Medsafe to the authorized user’s smartphone. The user can set specific instructions on the Medsafe to perform certain functions. The Medsafe grants the user entry by either the users fingerprint or keyfob to allow positive identification. The Medsafe has a proprietary cooling unit to allow optimal operating temperature. The Medsafe will communicate time, date, expirations, messages, battery life, etc. to the authorized user. The safe can reside anywhere and can be portable.


Q: Investorideas
I see from the website you are also developing vending machine technology for the medical marijuana industry.  Can you talk about that and is it the same technology behind it?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
It is the same technology on a much larger scale. We will incorporate the ability the accept currency, a user friendly touch-screen graphic display and have a product dispensing system. The device will also communicate information to the user or customer such as complementary cannabis vendors selling other products, along with our industry coupon program which will save the user money and offer new products. This will also be an advertising device where other suppliers can advertise their products.


Q: Investorideas
Your company also sells product lines of medical grade CBD and HEMP products online. Can you talk about that opportunity and what products you are currently selling?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
CBD or Cannabidiol is now legal in all 50 states. It is derived from the Hemp plant and is non-psychoactive. CBD does not get you high.  CBD has been recognized for its benefits on human and animal health and is capable of affecting nearly every biological process. CBD helps in overall health and well being from headaches to backaches to stress and anxiety.
PSI is selling in our online store multiple quality CBD products. PSI sells oils, gels, topical creams, lip balm, tinctures, vape products and pre-filled cartridges to help support health and wellness of our customers.


Q: Investorideas
Can you talk about any relationships in place in the medical marijuana industry that will enable you to enter the market?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
PSI has built strong relationships in many areas of the cannabis industry. We are involved with a dispensary in Oregon and have relationships with extraction companies, edibles manufacturers, growers of both Industrial and organic hemp, marijuana growers and ancillary product companies. Over the last three years we have built relationships that will allow our Medsafe a much easier barrier of entry into the market. We actually have our first order and are in the process of finalizing our prototypes getting ready for production.


Q: Investorideas
With multiple products and opportunities, where are you focusing your attention short term to build out the portfolio and revenue stream?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
The Medsafe will be the product that will bring long term substantial revenue into Profile. Currently our online sales and addition of new ancillary off the shelf products such as CBD, Vape Pens and security products will help the revenue stream with new distribution agreements.


Q: Investorideas
So what is next? Obviously funding will be a key factor–how much will you be raising and what are the timelines from funding to commercialization and sales if all goes well?

A: DORE SCOTT PERLER CHIEF EXECUTIVE OFFICER AND PRESIDENT
We are in the final stages of finishing up the Medsafe. We plan on exposing our products to the market via industry trade shows, advertising and partner participation along with social media. The company is currently looking to raise $300,000 to $500,000 for the execution of our business model and production of our products either through crowdfunding or equity based funding.


Investorideas
Thanks Dore, we will track your funding venture and product development and follow up soon.














About Profile Solutions, Inc. (OTC: PSIQ)
Profile Solutions, Inc. (OTC: PSIQ) A Security Technology developer, system designer and integrator, specializing in servicing Fortune 100 Customers, Law Enforcement and Government Agencies/Facilities, Medical and Recreational cannabis industry-related businesses. http://www.profilesolutionsinc.com/

The PSI MedSafe can also store jewelry, weapons, documents and other valuables or items.



About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.
  
Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow stocks in your favorite stock sector including cannabis stocks and hemp stocks with Investor Ideas stock directories http://www.investorideas.com/membership/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR, social media and publishing client and compensates Investorideas.com (effective April 4, 2016 - three thousand five hundred per month) more disclaimer info: http://www.investorideas.com/About/Disclaimer.asp  Disclosure : PSIQ is a paid PR and news client on Investorideas – more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

This press release includes "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of the "Company". Forward-looking statements are based on the expectations, estimates, or projections of the Company's management as of the date of this press release. Although  PSIQ  management believes these expectations, estimates, or projections to be reasonable as of the date of this presentation, forward-looking statements are inherently subject to significant business risks, economic and competitive uncertainties, or other contingencies, which could cause the Company's actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause PSIQ actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" sections in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2015, which is available for viewing on the SEC's EDGAR website. These forward-looking statements speak only as of the date of this press release and, except as required by law, Reign specifically disclaims any obligation to update these forward-looking statements, even if new information becomes available in the future

Contact Investorideas.com
800-665-0411


Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory